Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/10/1998US5834242 Human clathrin-associated protein
11/10/1998US5834241 Vesicle trafficking protein
11/10/1998US5834240 Therapy, prevention, diagnosis
11/10/1998US5834239 Polynucleotide sequence, a complementary sequence, expression vector and a culturable host cell; medical diagnosis; anticarcinogenic agents
11/10/1998US5834238 Human GTP binding protein
11/10/1998US5834235 Inferferon-α-induced protein
11/10/1998US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998US5834233 Cells transformed with a regulatably expressible gene whose expression results in the formation of a cytoplasmically active hydrolytic enzyme; expressing a pesticide or pollutant degrading proteins with said gene
11/10/1998US5834229 Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
11/10/1998US5834221 Contacting body fluid sample with immunological binding partner specific for 3-hydroxypyridinium crosslinked peptide derived from carboxy-terminal telopeptide domain of type i collagen
11/10/1998US5834210 Stable troponin subunits and complexes
11/10/1998US5834209 Bcl-x/bcl-2 associated cell death regulator
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5834179 Morphogenic protein compositions of matter
11/10/1998US5834032 Compositions and methods for treating diabetes
11/10/1998US5834029 Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
11/10/1998US5834028 Storage stable solutions with maltose, lactose or sucrose and arginine hydrochloride; for treatment or prevention of blood coagulation disorders
11/10/1998US5834017 Oral cyclopsporin formulations
11/10/1998US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same
11/10/1998US5834005 Implantable drug delivery capsules; polyxylylene membrane
11/10/1998US5834002 Water insoluble gum base with water soluble bulk portion, flavors, colloidal bismuth salts of hydroxy carboxylic aicds, for treating helicobacter pylori infections, antiulcer agents
11/10/1998US5834001 Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core
11/10/1998US5833991 A glycine-rich amino acid sequence is inserted into a fusion protein to prevent an immunogenic response; gene therapy; transfer vectors; vaccines
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833989 Complement receptor type 1 protein was encoded by plasmides having no more three inserted short consensus repeats nucleotide; use in inflammatory, brain, nevous system and immune disorders
11/10/1998US5833988 Noninvasive drug delivery across the blood-brain barrier by administering a conjugate of an antibody, and either a nerve growth factor or neurotrophic factor; treating alzheimer's disease, stroke, epilepsy, parkinson's disease
11/10/1998US5833987 Treatment of T cell mediated autoimmune disorders
11/10/1998US5833986 Methods of inhibiting the growth of neoplasia using a monoclonal antibody against α platelet derived growth factor receptor
11/10/1998US5833985 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
11/10/1998US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A
11/10/1998US5833982 Anticoagulants
11/10/1998US5833981 Human phosphorylase kinase gamma subunit
11/10/1998US5833976 Administering to reduce levels of tumor necrosis factor; modulation of interleukins 1 and 6; post-operative septic shock treatment
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/10/1998US5833974 Antitumor agents; hemoglobulin, polyoxyalkylene glycolconjugate
11/10/1998US5833953 Fluoridated micellar casein
11/10/1998US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
11/10/1998US5833942 Cyclic peptide derivatives of somatostatin; radiodiagnosis, therapy
11/10/1998CA2050786C An antimicrobial peptide and an antimicrobial composition
11/10/1998CA1340122C Modifications of somatotropins for enhanced stability
11/09/1998WO1998039438A1 Antisense compounds to cd14
11/09/1998CA2253877A1 Antisense compounds to cd14
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049561A1 Inhibitors of nuclear protein/nuclear receptor interaction
11/05/1998WO1998049335A1 Construct and expression of a retrovirus chimerical envelope by vectors, and pharmaceutical compositions containing same
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998WO1998049326A1 Method for cleavage of fusion proteins
11/05/1998WO1998049324A2 Carbohydrate-deficient glycoprotein syndrome type i
11/05/1998WO1998049322A1 Neurotrypsin
11/05/1998WO1998049321A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049312A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia
11/05/1998WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
11/05/1998WO1998049309A1 Rat st38.2 chemokine
11/05/1998WO1998049308A1 Ngf variants
11/05/1998WO1998049306A1 Human c-type lectin
11/05/1998WO1998049305A1 Chimeric opg polypeptides
11/05/1998WO1998049304A1 Neuronal extracellular matrix protein
11/05/1998WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998WO1998049302A1 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998049301A1 New human retinoid binding protein
11/05/1998WO1998049300A2 Truncated vegf-related proteins
11/05/1998WO1998049299A1 Leukemia associated genes
11/05/1998WO1998049298A1 Heat shock-like protein
11/05/1998WO1998049296A1 Human cerberus protein
11/05/1998WO1998049295A1 Ligand polypeptide for the g protein-coupled receptor from human pituitary glands
11/05/1998WO1998049293A1 Human theta subunit of the gaba-a receptor
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
11/05/1998WO1998049290A2 Syndecan interacting proteins and the use thereof
11/05/1998WO1998049288A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection
11/05/1998WO1998049287A2 Antisense oligonucleotides specific for thymidylate synthase
11/05/1998WO1998049279A1 Use of a zwitterionic detergent/surfactant for purifying glutamic acid decarboxylase (gad) and a composition containing gad
11/05/1998WO1998049278A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND β-GLUCANOLYTIC ENZYMES
11/05/1998WO1998049197A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/05/1998WO1998049196A1 Calcitonin receptor-binding peptides
11/05/1998WO1998049194A2 Ras-like protein
11/05/1998WO1998049193A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
11/05/1998WO1998049192A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049190A2 Substituted oxadiazole cysteine protease inhibitors
11/05/1998WO1998049189A1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta
11/05/1998WO1998049188A1 Inhibitors of the jnk signal transduction pathway and methods of use
11/05/1998WO1998049186A1 Dipeptide surrogates containing asparagine-derived tetrahydropyrimidinones
11/05/1998WO1998049168A1 Reverse-turn mimetics and methods relating thereto
11/05/1998WO1998049135A1 Compounds and compositions for delivering active agents
11/05/1998WO1998048873A1 Device for administering insulin in controlled dosages by controlling total inhaled volume
11/05/1998WO1998048840A1 Polyethylene glycol-interferon alpha conjugates for therapy of infection
11/05/1998WO1998048832A1 Nerve growth factor as a vaccine adjuvant
11/05/1998WO1998048831A1 Leptin as an inhibitor of tumor cell proliferation
11/05/1998WO1998048830A1 Method for promoting myogenesis using osteogenic proteins
11/05/1998WO1998048829A1 A vertebrate lens obtained from an ectodermal cell and methods of use thereof
11/05/1998WO1998048828A1 Method of treating sepsis
11/05/1998WO1998048827A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/05/1998WO1998048826A1 Inhibition of nitric oxide synthase by amino acids and dipeptides
11/05/1998WO1998048825A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
1 ... 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 ... 3163